Experimental drug targets uncontrollable hunger in rare genetic disorder
NCT ID NCT06772597
Summary
This study is testing whether a daily injection called setmelanotide can help people with Prader-Willi Syndrome manage their weight and reduce extreme hunger behaviors. About 20 participants aged 6-65 will receive the medication for up to one year while researchers monitor safety and weight changes. The goal is to see if this treatment can provide better control over the challenging symptoms of this genetic condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida
Gainesville, Florida, 32610-0296, United States
Conditions
Explore the condition pages connected to this study.